186 related articles for article (PubMed ID: 38296800)
1. Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases.
Fatica M; Monosi B; Conigliaro P; D'Antonio A; Essofi S; Cuccagna E; Bergamini A; Biancone L; Monteleone G; Triggianese P; Calabrese E; Chimenti MS
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296800
[TBL] [Abstract][Full Text] [Related]
2. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P
J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702
[TBL] [Abstract][Full Text] [Related]
3. Four-year follow-up of atherogenicity in rheumatoid arthritis patients: from the nationwide Korean College of Rheumatology Biologics Registry.
Min HK; Kim HR; Lee SH; Shin K; Kim HA; Park SH; Kwok SK
Clin Rheumatol; 2021 Aug; 40(8):3105-3113. PubMed ID: 33576925
[TBL] [Abstract][Full Text] [Related]
4. Extra-articular disease in patients with spondyloarthritis. Baseline characteristics of the spondyloarthritis cohort of the AQUILES study.
Zarco P; González CM; Rodríguez de la Serna A; Peiró E; Mateo I; Linares L; Calvo J; Cea-Calvo L; Arteaga MJ; Vanaclocha F; Marín-Jiménez I; García-Vicuña R
Reumatol Clin; 2015; 11(2):83-9. PubMed ID: 25441489
[TBL] [Abstract][Full Text] [Related]
5. Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach.
Chimenti MS; Conigliaro P; Triggianese P; Canofari C; Cedola F; Onali S; Calabrese E; Romeo S; Neri B; De Cristofaro E; Biancone L; Perricone R
Clin Exp Rheumatol; 2019; 37(5):723-730. PubMed ID: 31172920
[TBL] [Abstract][Full Text] [Related]
6. Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis.
Acosta Felquer ML; LoGiudice L; Galimberti ML; Rosa J; Mazzuoccolo L; Soriano ER
Ann Rheum Dis; 2022 Jan; 81(1):74-79. PubMed ID: 34281904
[TBL] [Abstract][Full Text] [Related]
7. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis.
Ono K; Kishimoto M; Deshpande GA; Fukui S; Kawaai S; Sawada H; Matsuura M; Rodriguez VR; Proft F; Tada K; Tamura N; Taniguchi Y; Hirata A; Kameda H; Tsuji S; Kaneko Y; Dobashi H; Okano T; Haji Y; Morita A; Okada M; Komagata Y; Medina CL; Molto A; Dougados M; Hisamatsu T; Tomita T; Kaname S
Rheumatol Int; 2022 Oct; 42(10):1751-1766. PubMed ID: 35532790
[TBL] [Abstract][Full Text] [Related]
9. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
[TBL] [Abstract][Full Text] [Related]
10. Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases.
Elewaut D; Braun J; Anderson JK; Arikan D; Chen S; Hojnik M; De Craemer AS; Curtis JR
Arthritis Care Res (Hoboken); 2021 Feb; 73(2):289-295. PubMed ID: 32100944
[TBL] [Abstract][Full Text] [Related]
11. Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain.
Martinis F; Tinazzi I; Bertolini E; Citriniti G; Variola A; Geccherle A; Marchetta A; McGonagle D; Macchioni P
Rheumatology (Oxford); 2020 Oct; 59(10):2857-2863. PubMed ID: 32068873
[TBL] [Abstract][Full Text] [Related]
12. Screening for spondyloarthritis in patients with inflammatory bowel diseases.
Ottaviani S; Tréton X; Forien M; Coralli R; Dauchez A; Stefanescu C; Pelletier AL; Becheur H; Ebstein E; Bouhnik Y; Dieudé P
Rheumatol Int; 2023 Jan; 43(1):109-117. PubMed ID: 36161358
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of spondyloarthritis symptom in inflammatory bowel disease patients: A questionnaire survey.
Kamo K; Shuto T; Haraguchi A
Mod Rheumatol; 2015 May; 25(3):435-7. PubMed ID: 25381725
[TBL] [Abstract][Full Text] [Related]
15. Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis: Results From Two Belgian Nationwide Axial Spondyloarthritis Cohorts.
Varkas G; Vastesaeger N; Cypers H; Colman R; Renson T; Praet LV; Carron P; Raeman F; Devinck M; Gyselbrecht L; Corluy L; Piette Y; Lenaerts J; Thevissen K; Vanneuville B; Bosch FVD; Elewaut D
Arthritis Rheumatol; 2018 Oct; 70(10):1588-1596. PubMed ID: 29740978
[TBL] [Abstract][Full Text] [Related]
16. Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease.
Ben Nessib D; Ferjani H; Maatallah K; Rahmouni S; Kaffel D; Hamdi W
Clin Rheumatol; 2020 Dec; 39(12):3543-3553. PubMed ID: 32424656
[TBL] [Abstract][Full Text] [Related]
17. Malignancies in spondyloarthritis with and without concomitant psoriasis, and the effect of disease modifying anti-rheumatic drugs.
Chung HY; Chan SCW; Chui ETF; Yau T; Lau CS
Clin Exp Rheumatol; 2022 May; 40(5):913-920. PubMed ID: 34369368
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.
Beslek A; Onen F; Birlik M; Akarsu M; Akar S; Sari I; Gurler O; Akpinar H; Manisali M; Akkoc N
Rheumatol Int; 2009 Jun; 29(8):955-7. PubMed ID: 19082597
[TBL] [Abstract][Full Text] [Related]
19. SpA plus IBD or IBD plus SpA: Does commutative property apply?
Carubbi F; Alunno A; Viscido A; Baraliakos X; Mariani FM; Di Ruscio E; Altieri P; Ferri C
Autoimmun Rev; 2023 Oct; 22(10):103443. PubMed ID: 37678619
[TBL] [Abstract][Full Text] [Related]
20. Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment.
Zhou J; Huang W; Zhang Z; Luo L; Ren F; Huang D; Tang L
Clin Rheumatol; 2023 Dec; 42(12):3251-3255. PubMed ID: 37740841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
